vimarsana.com

Latest Breaking News On - Bright green company profile - Page 1 : vimarsana.com

Bright Green Co (NASDAQ:BGXX) Short Interest Up 28 0% in March

Bright Green Co. (NASDAQ:BGXX – Get Free Report) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 3,570,000 shares, a growth of 28.0% from the February 29th total of 2,790,000 shares. Based on an average trading volume of 1,930,000 shares, the days-to-cover ratio […]

Financial Analysis: Bright Green (BGXX) and The Competition

Bright Green (NASDAQ:BGXX – Get Rating) is one of 58 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it compare to its peers? We will compare Bright Green to similar companies based on the strength of its dividends, institutional ownership, risk, profitability, analyst recommendations, valuation and earnings. Analyst Ratings This is a […]

Critical Survey: Bright Green (BGXX) & Its Competitors

Bright Green (NASDAQ:BGXX – Get Rating) is one of 55 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it weigh in compared to its competitors? We will compare Bright Green to similar companies based on the strength of its dividends, analyst recommendations, valuation, earnings, profitability, institutional ownership and risk. Insider and Institutional […]

Bright Green Co (NASDAQ:BGXX) Sees Large Increase in Short Interest

Bright Green Co. (NASDAQ:BGXX – Get Rating) was the target of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 3,650,000 shares, an increase of 6.4% from the May 15th total of 3,430,000 shares. Based on an average daily trading volume, of 849,800 shares, […]

Analyzing Bright Green (BGXX) and The Competition

Bright Green (NASDAQ:BGXX – Get Rating) is one of 56 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it contrast to its peers? We will compare Bright Green to similar businesses based on the strength of its valuation, dividends, risk, earnings, analyst recommendations, institutional ownership and profitability. Valuation & Earnings This table […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.